BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Falco A, Leiva M, Blanco A, Cefarelli G, Rodriguez A, Melo J, Cayol F, Rizzo MM, Sola A, Rodríguez Montani H, Chacon M, Enrico D, Waisberg F. First-line cisplatin, docetaxel, and cetuximab for patients with recurrent or metastatic head and neck cancer: A multicenter cohort study. World J Clin Oncol 2022; 13(2): 147-158 [PMID: 35316930 DOI: 10.5306/wjco.v13.i2.147]
URL: https://www.wjgnet.com/2218-4333/full/v13/i2/147.htm
Number Citing Articles
Christopher M. Black, Dandan Zheng, Gleicy M. Hair, Lei Ai, Liya Wang, Daisuke Goto, Nati Lerman, Behzad Bidadi, Glenn J. Hanna. Real-world use of first-line pembrolizumab + platinum + taxane combination regimens in recurrent / metastatic head and neck squamous cell carcinomaFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1348045
Ai-Ho Liao, Yu-An Lee, Dao-Lung Lin, Ho-Chiao Chuang, Jehng-Kang Wang, Ching-En Chang, Hsiang-Tzu Li, Ting-Yi Wu, Cheng-Ping Shih, Chih-Hung Wang, Yueng-Hsiang Chu. Treatment efficacy of low-dose 5-fluorouracil with ultrasound in mediating 5-fluorouracil-loaded microbubble cavitation in head and neck cancerDrug Delivery 2023; 30(1): 1 doi: 10.1080/10717544.2022.2154410